Lionheart Health Recognized as Finalist in Octane's 2025 High Tech Awards for Medical Technology Innovation

Lionheart Health, Inc. has been recognized as a finalist in the category of Best Innovation in Medical Technology Life Sciences in the prestigious High Tech Awards organized by Octane. This recognition underscores the company's commitment to driving breakthrough healthspan innovations and creating impactful solutions that benefit humankind through its advanced bioelectric and biologics technologies.

The company's flagship development is a whole body regeneration chamber described as a womb for adults designed to extend healthspan longevity by 20 years. Powered by AI and precise robotics, the multi-modality device is driven by bioelectrically-controlled and enhanced biologics intended to regenerate organs throughout the human body, including hearts, kidneys, brains, livers, pancreas, lungs, skin, eyes, and multiple other systems. This innovative approach represents a significant advancement in regenerative medicine and longevity science.

Lionheart Health's primary business model involves licensing its patented technology platform to qualified clinics worldwide. The company has collaborated with manufacturing partners including Mettler Electronics of Anaheim, California, and has secured FDA 510K market clearances for using targeted bioelectric stimulation to improve circulation, build and recover muscle strength, reduce pain and inflammation, treat arthritis including joint osteoarthritis, prevent blood clots, enhance exercise benefits, and improve stroke recovery. These technologies are integrated into products addressing skin and hair health, sexual health vitality, joint pain recovery, rapid body toning, weight management, and chronic inflammation reduction.

The company's recent achievements include winning the AbbVie Allergan ULP Innovation in Medical Aesthetics Award, the Medtech Outlook Stimulator Development of the Year 2025 Award, and being selected as one of 40 semi-finalists in the $101 million XPRIZE Healthspan Competition. Lionheart Health was also announced as a finalist for the Orange County Business Journal Innovator of the Year 2025 Award, further establishing its position in the healthcare innovation landscape. Additional information about the company's technologies and research can be found at https://www.LionheartLongevity.com.

Howard Leonhardt, Executive Chairman and Co-CEO, stated that this recognition serves as a testament to the company's dedication to advancing longevity and healthspan through innovation. The Octane 2025 Technology Awards Ceremony will take place on September 25th, 2025, in Irvine, with registration available at https://www.octane-oc.org/event/e891a457-c212-43fa-9c31-c35a57002cd9/2025-finalists. Lionheart Health is also sponsoring The Klotho Conference in Irvine on September 15th and 16th, 2025, where attendees can learn about elevating klotho levels to increase healthspan, with conference details at https://www.klothoconference.com.

The company's research has demonstrated that exercising with their patented BodStim EMS suit can substantially increase circulating klotho levels compared to ordinary exercise, representing another innovative approach to healthspan extension. Individuals interested in assessing their klotho levels can order testing through https://www.KlothoYears.com, while additional information about the EMS technology is available at https://www.bodstim.com. These developments position Lionheart Health at the forefront of the growing longevity and regenerative medicine industry, contributing to Orange County's reputation as a significant hub for disruptive healthcare innovation.